| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
3.56 -0.04 (-0.01%) |
07-16 16:00 |
|
Open: |
3.56 |
Pre close: |
3.6 |
Target:
|
4.38 
|
|
High: |
3.625 |
Low: |
3.545 |
Resistance:
|
3.75
3.98
|
|
Volume: |
589,350 |
Market Cap: |
393M |
Support:
|
3.37
2.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.60
 |
MACD |
MACD(12,26):
|
-0.19 |
|
MA(20): |
3.63 |
Signal(12,26,9): |
-0.26 |
|
MA(100): |
6.31 |
Stochastic Oscillator |
%K(14,3):
|
25.06 |
|
MA(250): |
7.15 |
%D(3): |
29.88 |
|
Average Volume(K) |
3-Month: |
237821
|
52-Week |
High:
|
9.95 |
|
10-Days: |
108806 |
Low: |
2.80 |
|
RSI |
RSI(14):
|
39.98 |
Change(%): |
-43.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.004 |
Return on Equity (ttm) |
-252.0 |
Shares Out. (M) |
110.31 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-39.9 |
Shares Float (M) |
60.15 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
-0.15 |
% Held by Insiders |
1.04 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
48.1 |
% Held by Institutions |
93.64 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
-0.587 |
Shares Short (K) |
11110 |
|
Book Value (p.s.) |
0.200 |
EBITDA (p.s.) |
-0.855 |
P/E |
-3.58 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
17.95 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-99.91 |
P/S |
1885775744.00 |
|
Operating Margin |
-421.18 |
Levered Free Cash Flow
(M) |
-55.84 |
P/CF |
-3.96 |
|
|
|
|
|
|
